SCHEMBL9312201

SCHEMBL9312201

COc1ccc2c3c1CCCC3CN(C)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10468072 0.95
SCHEMBL10468680 0.90
SCHEMBL10469020 0.82 HTR2A (0.47)
SCHEMBL9312927 0.81
SCHEMBL10468666 0.81
SCHEMBL10469645 0.77 PDE4B (0.46)
SCHEMBL10468899 0.76 PDE4A (0.44)
SCHEMBL10467274 0.75 HTR1A (0.45)
SCHEMBL10467971 0.75
SCHEMBL10468907 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374722-A Treating psychoses SCHERING CORPORATION (US) 1994-12-20 US disclosed
WO-1992005157-A1 PERI-CONDENSED BENZAZEPINES SCHERING CORPORATION (US) 1992-04-02 WO disclosed